DEFINITIONS

“CCASS Investor Participant”

a person admitted to participate in CCASS as an investor
participant who may be an individual or joint individuals
or a corporation

“CCASS Participant”

a CCASS Clearing Participant, a CCASS Custodian
Participant or a CCASS Investor Participant

“Cheng Yu Investments”

“China” or “PRC”

“China Life”

“Companies Ordinance”

Cheng Yu Investments Limited, a business company
incorporated under the laws of the British Virgin Islands
and one of our Pre-IPO Investors

the People’s Republic of China and for the purposes of
this prospectus only, except where the context requires
otherwise, excludes Hong Kong, Macau and Taiwan

China Life Chengda (Shanghai) Healthcare Industry
Equity Investment Center (Limited Partnership) (國壽成
達(上海)健康產業股權投資中心(有限合夥)),
limited
partnership established under the laws of the PRC on
November 11, 2016 and one of our Pre-IPO Investors

a

the Companies Ordinance (Chapter 622 of the Laws of
Hong Kong), as amended, supplemented or otherwise
modified from time to time

“Companies (Winding Up and

Miscellaneous Provisions)
Ordinance”

(Winding Up

and Miscellaneous
the Companies
Provisions) Ordinance (Chapter 32 of the Laws of Hong
Kong), as amended, supplemented or otherwise modified
from time to time

“Company”, “our Company”,

or “the Company”

Innovent Biologics, Inc. (信達生物製藥), an exempted
company with limited liability incorporated under the
laws of the Cayman Islands on April 28, 2011

“connected person(s)”

has the meaning ascribed to it under the Listing Rules

“connected transaction(s)”

has the meaning ascribed to it under the Listing Rules

“Cormorant Global Healthcare”

Cormorant Global Healthcare Master Fund, LP, an
exempted limited partnership registered under the laws of
Cayman Islands on April 2, 2013 and one of our Pre-IPO
Investors

– 21 –

